Immunological Insights from Patients Undergoing Surgery on Ipilimumab for Metastatic Melanoma

BACKGROUND. The tumor microenvironment after treatment with ipilimumab is not well described. Furthermore, the safety of surgery for patients being treated with ipilimumab for metastatic melanoma has not been well reported. This study analyzed the safety of surgery and the immune phenotype of tumors...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg Oncol
Principais autores: Gyorki, David E., Yuan, Jianda, Mu, Zhenyu, Zaidi, Bushra, Pulitzer, Melissa, Busam, Klaus, Brady, Mary S., Coit, Daniel G., Allison, James P., Wolchok, Jedd D., Ariyan, Charlotte E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6405339/
https://ncbi.nlm.nih.gov/pubmed/23681603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-013-2999-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados